Status
Conditions
Treatments
About
This prospective single-arm pilot study will evaluate the application of meshed 5 × 7 cm Restrata® sheets to the abdominal wall donor site following deep inferior epigastric perforator (DIEP) or abdominal wall autologous free tissue transfer in 20 eligible patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Current smoker.
Body mass index > 39.9.
Received systemic chemotherapy within 4 weeks prior to the scheduled DIEP or abdominal wall autologous free tissue transfer procedure.
Uncontrolled diabetes mellitus determined by the investigator.
*Note: if there is documentation of HgbA1c > 12% within 3 months of the scheduled DIEP or abdominal wall autologous free tissue transfer procedure, it will need to be reviewed by the PI to determine the patient's clinical situation and eligibility.
Pregnant.
Currently receiving any investigational agents.
Known sensitivity to resorbable sutures (polyglactin 910, polydioxanone).
Primary purpose
Allocation
Interventional model
Masking
20 participants in 1 patient group
Loading...
Central trial contact
Justin Sacks, MD, MBA, FACS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal